Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H21N3O |
Molecular Weight | 259.3467 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC2(CC1)NCC(=O)N2CC3=CC=CC=C3
InChI
InChIKey=BSQPTZYKCAULBH-UHFFFAOYSA-N
InChI=1S/C15H21N3O/c1-17-9-7-15(8-10-17)16-11-14(19)18(15)12-13-5-3-2-4-6-13/h2-6,16H,7-12H2,1H3
Molecular Formula | C15H21N3O |
Molecular Weight | 259.3467 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:43:42 GMT 2023
by
admin
on
Sat Dec 16 13:43:42 GMT 2023
|
Record UNII |
6NV440YIO0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11778
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
300000039107
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
6NV440YIO0
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
1224591-33-6
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
46195331
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
HI-110
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY | |||
|
C180661
Created by
admin on Sat Dec 16 13:43:42 GMT 2023 , Edited by admin on Sat Dec 16 13:43:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
PTI-125 is a filamin A (FLNA) binding compound. By restoring FLNA’s native conformation, the sponsor hypothesizes that PTI-125 prevents or reverses the FLNA – α7-nicotinic acetylcholine receptor (α7nAChR) association and beta amyloid1-42 (Aβ42) toxic signaling via α7nAChR, thereby preventing the development of neurofibrillary tangles and subsequent neurodegeneration.
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |